Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients (Q40338985)
Appearance
scientific article published on December 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients |
scientific article published on December 2005 |
Statements
1 reference
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients (English)
1 reference
Zora Modrusan
1 reference
Robert L Yauch
1 reference
Thomas Januario
1 reference
David A Eberhard
1 reference
Guy Cavet
1 reference
Wenjing Zhu
1 reference
Ling Fu
1 reference
Thinh Q Pham
1 reference
Robert Soriano
1 reference
Jeremy Stinson
1 reference
Somasekar Seshagiri
1 reference
Chin-Yu Lin
1 reference
Vincent O'Neill
1 reference
Lukas C Amler
1 reference
1 December 2005
1 reference
1 reference
11
1 reference
24 Pt 1
1 reference
8686-8698
1 reference
Identifiers
1 reference
1 reference